Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

INMB

INMB News

Newswire

07:05

INmune Bio's CORDStrom Platform Featured in Peer-Reviewed Journal Cytotherapy

07:01

"Therapeutic Potential of Stromal Cell Therapies Highlighted in Peer-Reviewed Study"

08:08

INmune Bio's XPro1595 shows promising results in Phase 2 MINDFuL trial for Alzheimer's.

08:02

INmune Bio Reports New Phase 2 Grey Matter Imaging Data Reinforcing XPro1595's Potential in Alzheimer's Patients

08:05

INmune Bio to Present at CTAD Conference on Alzheimer's Disease Treatments.

View More

About INMB

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More